CAR T-Cell Therapy
Written by: Emily Downward | Last reviewed: February 2018
View References
- CAR T-cell therapy approved for some children and young adults with leukemia, National Cancer Institute. Available at https://www.cancer.gov/news-events/cancer-currents-blog/2017/tisagenlecleucel-fda-childhood-leukemia. Accessed 2/15/18.
- With FDA approval for advanced lymphoma second CAR T-cell therapy moves to the clinic, National Cancer Institute. Available at https://www.cancer.gov/news-events/cancer-currents-blog/2017/yescarta-fda-lymphoma. Accessed 2/15/18.
- CAR T cells: expanding into multiple myeloma, National Cancer Institute. Available at https://www.cancer.gov/news-events/cancer-currents-blog/2017/car-t-cell-multiple-myeloma. Accessed 2/15/18.
- CAR T cells: engineering patients' immune cells to treat their cancers, National Cancer Institute. Available at https://www.cancer.gov/about-cancer/treatment/research/car-t-cells. Accessed 2/15/18.
- Kymriah product website, Novartis Pharmaceuticals. Available at https://www.us.kymriah.com/acute-lymphoblastic-leukemia-children/interested-in/treatment-information/. Accessed 2/16/18.
- Kymriah prescribing information, Novartis Pharmaceuticals. Available at https://www.pharma.us.novartis.com/sites/www.pharma.us.novartis.com/files/kymriah.pdf. Accessed 2/16/18.
- Urciuoli B. FDA approves CAR-T cell therapy for diffuse large B-cell lymphoma. Cure Today. Available at https://www.curetoday.com/articles/fda-approves-cart-cell-therapy-for-diffuse-large-b-cell-lymphoma. Accessed 5/9/18.
- Yescarta product website, Kite Pharma. Available at https://www.yescarta.com/. Accessed 2/16/18.
- Yescarta prescribing information, Kite Pharma. Available at https://www.yescarta.com/wp-content/uploads/yescarta-pi.pdf. Accessed 2/16/18.
- Rosenbaum L. Tragedy, perseverance, and chance - the story of CAR-T therapy. N Engl J Med 2017;377:1313-1315. doi: 10.1056/NEJMp1711886.